Warminster, PA. – Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Mark Murray, Arbutus’ President and CEO, will present a… Read More
Warminster, PA. – Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its fourth quarter and year-end 2018 financial… Read More
Stoke Therapeutics and Xenon Pharmaceuticals Join Founders BioMarin and Invitae to Offer a No-Cost Epilepsy Gene Panel Testing Program for Children Up to 60 Months Who Have Had an Unprovoked… Read More
VANCOUVER, BC – Life Sciences BC is pleased to announce the recipients of the 21st Annual Life Sciences BC Awards, presented by FARRIS. These awards are presented annually to recognize… Read More
VANCOUVER, BC and SAN DIEGO, CA. – Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced today that Dr. Sandra Dunn, PhoenixMD’s Chief Executive Officer, will… Read More
